PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 247 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q1 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $301 | -37.3% | 36,100 | 0.0% | 0.00% | -33.3% |
| Q2 2023 | $480 | +14.8% | 36,100 | 0.0% | 0.00% | +50.0% |
| Q1 2023 | $418 | +41.7% | 36,100 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $295 | -99.9% | 36,100 | 0.0% | 0.00% | +100.0% |
| Q3 2022 | $210,000 | +31.2% | 36,100 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $160,000 | -40.3% | 36,100 | +22.8% | 0.00% | 0.0% |
| Q1 2022 | $268,000 | -67.5% | 29,400 | -27.0% | 0.00% | -75.0% |
| Q4 2021 | $825,000 | -17.2% | 40,300 | +3.3% | 0.00% | -20.0% |
| Q3 2021 | $996,000 | -27.0% | 39,000 | 0.0% | 0.01% | -28.6% |
| Q2 2021 | $1,364,000 | +40.2% | 39,000 | +33.6% | 0.01% | +16.7% |
| Q1 2021 | $973,000 | +5.6% | 29,200 | -17.7% | 0.01% | 0.0% |
| Q4 2020 | $921,000 | – | 35,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ORACLE INVESTMENT MANAGEMENT INC | 1,446,459 | $48,182,000 | 7.22% |
| BOURNE LENT ASSET MANAGEMENT INC | 536,800 | $17,881,000 | 5.70% |
| Casdin Capital, LLC | 5,000,000 | $166,550,000 | 4.96% |
| Iron Triangle Partners LP | 935,805 | $31,172,000 | 3.96% |
| Jackson Square Partners, LLC | 12,911,695 | $430,088,000 | 2.44% |
| SB Management Ltd | 9,861,089 | $328,473,000 | 2.12% |
| Abacus Planning Group, Inc. | 180,000 | $5,996,000 | 1.92% |
| BERKSHIRE CAPITAL HOLDINGS INC | 413,800 | $13,784,000 | 1.57% |
| ARK Investment Management | 21,301,191 | $709,543,000 | 1.41% |
| Nikko Asset Management Americas, Inc. | 5,247,237 | $174,785,000 | 0.86% |